You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer

  • Technology appraisal guidance
  • Reference number: TA263
  • Published:  22 August 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Information for the public

  • Bevacizumab with capecitabine as first-line treatment for metastatic breast cancer (PDF 180 KB)

    Published:
    22 August 2012
  • Gwybodaeth i'r cyhoedd (Word 158 KB)

    Published:
    15 October 2012
Back to top